In this issue:
Apatinib + PLD vs. PLD alone for platinum-resistant recurrent ovarian cancer
Prognostic value of FAM19A4/ miR124-2 methylation for regression in untreated CIN 2/3
Prognostic profile predictors of OS & DFS in early-stage endometrial cancer
Survival & characteristics of ovarian carcinosarcoma vs. HGSOC
A gross morphologic classification system for HGSOC subtypes
Metabolic screening to distinguish ovarian cancer vs. benign pelvic masses
POLE status in endometrial carcinoma
Chemo-radiation vs. radiation vs. chemo in stage 1-4 surgically treated uterine carcinosarcoma
Determinants of relapse & DFS in stage 2-4 LGSOC after contemporary primary therapy
Clinical outcomes for gynaecologic oncology patients with COVID-19
Please login below to download this issue (PDF)